Beth Israel Deaconess Medical Ctr, Beth Israel Lahey Health
- Academic, tech transfer
- Institute, hospital research
Beth Israel Lahey Health (BILH) is the 2nd -largest healthcare system in New England, with over $400 million in annual research funding. Our system includes Beth Israel Deaconess Medical Center and Joslin Diabetes Center, both Harvard Medical School affiliates, as well as Lahey Medical Center and New England Baptist Orthopedic Hospital, a leader in orthopedic care.
Our research enterprise is organized around 5 Translational Research Hubs:
- CV-MET
- ONC
- Inflam Infectious Diseases
- Neuro & Psych
- Ortho
We have a track record of impactful industry collaboration, having contributed to the discovery or target identification of over 50 approved products, generating more than $150 billion in cumulative sale including:
- The cardiac pacemaker (Prof. Paul Zoll, BIDMC)
- Avastin and Lucentis (Prof. Harold Dvorak, BIDMC; Prof. George King, Joslin)
- The J&J COVID-19 vaccine (Prof. Dan Barouch, BIDMC)
We are eager to explore new partnerships to accelerate therapeutic innovation.
Address
BostonMassachusetts
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}